Widow Spider Envenomation Follow-up

  • Author: Sean P Bush, MD, FACEP; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Oct 28, 2010
 

Further Inpatient Care

Admission to the hospital is indicated to the following patients:

  • Severely symptomatic children[10]
  • Pregnant women
  • Patients with a history of hypertension or heart disease
  • Patients with intractable pain and contraindications to antivenom
  • Patients with unusual complications of envenomation
  • Patients who develop anaphylaxis to antivenom

Discharge patients who experience relief with opioid analgesics, sedative-hypnotics, and/or antivenom (after a period of observation). Antivenom administration may reduce the need for hospitalization.

Next

Further Outpatient Care

Instruct patients to return if any of the following symptoms occur:

  • Hematuria
  • Rash
  • Joint pain
  • Swollen lymph nodes
  • Difficulty breathing
  • Signs of infection

Advise patients that if treated symptomatically with pain medications and benzodiazepines, pain may come and go for up to days to weeks after envenomation.

If patients have been treated with antivenom, discuss signs of serum sickness (as noted above) and warn them of its possible occurrence in 3-14 days.

Previous
Next

Inpatient & Outpatient Medications

Antihistamines and steroids should be given if serum sickness to antivenom develops. This is rare because treatment of widow spider envenomation usually requires only 1-2 vials of antivenom, and serum sickness usually occurs when more antivenom is given.

Previous
Next

Deterrence/Prevention

Pesticides may prevent exposures to widow spiders at home.

Previous
Next

Complications

Complications may include the following:

  • Respiratory difficulty, reactive airway exacerbation
  • Spontaneous abortion or preterm labor
  • Hypertensive emergency with or without associated seizures (isolated normotensive seizures have not been described), acute myocardial infarction
  • Rhabdomyolysis
  • Priapism (rare)
  • Compartment syndrome (rare)[13]
  • Toxic myocarditis (rare)
  • Antivenom-associated complication: Anaphylaxis, a type I (immediate) hypersensitivity reaction that may be life threatening, is characterized by urticaria, wheezing, and shock. It may occur to some degree in as many as 25% of patients given antivenom. Risk factors may include previous exposure to horse serum or antivenom or a history of reactive airways. It is treated with epinephrine, antihistamines, steroids, and ventilatory/circulatory support. One death has been reported from anaphylaxis to widow spider antivenom in the United States. The patient had a history of asthma and, after antivenom was administered, developed severe bronchospasm unresponsive to medical therapy.
  • Antivenom-associated complication: Serum sickness, a type III (delayed) hypersensitivity reaction characterized by fever, urticaria, lymphadenopathy, and arthritis, may occur 5 days to 3 weeks after antivenom administration. It usually is benign, self-limited, and treated with antihistamines and steroids. Serum sickness is dose related and uncommon following administration of widow spider antivenom because of the small amounts generally needed (1 or 2 vials).
Previous
Next

Prognosis

The vast majority of patients with widow spider envenomations recover fully.

Previous
Next

Patient Education

For excellent patient education resources, visit eMedicine's Bites and Stings Center. Also, see eMedicine's patient education articles, Black Widow Spider Bite and Brown Recluse Spider Bite.

Previous
 
Contributor Information and Disclosures
Author

Sean P Bush, MD, FACEP  Professor of Emergency Medicine, Loma Linda University School of Medicine; Consulting Staff, Envenomation Specialist, Department of Emergency Medicine, Loma Linda University Medical Center

Sean P Bush, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, International Society on Toxicology, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Protherics Consulting fee Consulting; Nycomed (formerly Fougera) Grant/research funds Speaking and teaching; Rare Disease Therapeutics Grant/research funds Research; Bioclon Grant/research funds Research

Coauthor(s)

Jennifer C Smith, MD  Medical Toxicology Fellow, Banner Good Samaritan Poison Center

Jennifer C Smith, MD is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert L Norris, MD  Professor, Department of Surgery, Chief, Division of Emergency Medicine, Stanford University Medical Center

Robert L Norris, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, California Medical Association, International Society of Toxinology, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD  Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

James Steven Walker, DO, MS  Clinical Professor of Surgery, Department of Surgery, University of Oklahoma College of Medicine

James Steven Walker, DO, MS is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, and American Osteopathic Association

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

References
  1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green J, Rumack BH, Heard SE. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol (Phila). Dec 2007;45(8):815-917. [Medline].

  2. Langley RL, Morrow WE. Deaths resulting from animal attacks in the United States. Wild Environ Med. 1997;8:8-16.

  3. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2004;22(5):335-404. [Medline].

  4. Gonzalez Valverde FM, Gomez Ramos MJ, Menarguez Pina F, Vazquez Rojas JL. [Fatal latrodectism in an elderly man]. Med Clin (Barc). Sep 22 2001;117(8):319. [Medline].

  5. Pneumatikos IA, Galiatsou E, Goe D, Kitsakos A, Nakos G, Vougiouklakis TG. Acute fatal toxic myocarditis after black widow spider envenomation. Ann Emerg Med. Jan 2003;41(1):158. [Medline].

  6. Hoxha R. Two Albanians die from black widow spider bites. BMJ. Aug 5 2006;333(7562):278. [Medline].

  7. Boyer Hassen LV, McNally JT, Binford GJ. Spider bites. In: Auerbach PS, ed. Wilderness Medicine. 4th ed. St. Louis: Mosby-Year Book; 2001:807-838.

  8. Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med. Jul 1992;21(7):782-7. [Medline].

  9. Bush SP, Thomas TL, Chin ES. Envenomations in children. Pediatr Emerg Med Rep. 1997;2:1-12.

  10. Woestman R, Perkin R, Van Stralen D. The black widow: is she deadly to children?. Pediatr Emerg Care. Oct 1996;12(5):360-4. [Medline].

  11. Bush SP. Black widow spider envenomation mimicking cholecystitis. Am J Emerg Med. May 1999;17(3):315. [Medline].

  12. Allen RC, Norris RL. Delayed use of widow spider antivenin. Ann Emerg Med. Sep 1995;26(3):393-4. [Medline].

  13. Cohen J, Bush S. Case report: compartment syndrome after a suspected black widow spider bite. Ann Emerg Med. Apr 2005;45(4):414-6. [Medline].

  14. Bush SP, Naftel J. Injection of a whole black widow spider. Ann Emerg Med. Apr 1996;27(4):532-3. [Medline].

Previous
Next
 
Black widow spider (Latrodectus mactans) with egg sac. Photo by Sean Bush, MD.
Black widow spider (Latrodectus mactans) and offspring. Photo by Sean Bush, MD.
Black widow spider. Reprinted with permission from Cutis 1995; 56: 257.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.